Objective Visual Quality Analysis System is Used in Cataract
Launched by WUHAN CHILDREN'S HOSPITAL, TONGJI MEDICAL COLLEGE, HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY · Feb 13, 2021
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
The Objective Visual Quality Analysis System (OQAS) is a new inspection technology used to objectively assess the visual quality of the human eye. It can detect the impact of ocular refractive system diseases on the objective visual quality of patients. It is currently mainly used to assess the progress of cataracts and help selection the timing of surgery has achieved good clinical results. Before the emergence of OQAS, the rating of cataracts largely relied on the subjective experience of physicians, and OQAS could accurately assess the effects of cataracts on the visual quality of the hu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Cataract patients aged 18-90 or patients after cataract surgery;
- • 2. Signed and dated informed consent;
- • 3. Commit to abide by the research procedures and cooperate with the implementation of the whole process research
- Exclusion Criteria:
- • 1. Obvious conjunctivitis;
- • 2. Obvious corneal epithelial punctate staining, corneal epithelial shedding;
- • 3. Keratitis;
- • 4. Uveitis;
- • 5. Corneal scar;
- • 6. Severe vitreous opacity or hemorrhage;
- • 7. Other situations deemed unsuitable for inclusion in this study after evaluation by ophthalmologists.
About Wuhan Children's Hospital, Tongji Medical College, Huazhong University Of Science And Technology
Wuhan Children's Hospital, affiliated with Tongji Medical College of Huazhong University of Science and Technology, is a leading pediatric healthcare institution in China. Renowned for its comprehensive clinical services, advanced research capabilities, and commitment to child health, the hospital plays a pivotal role in medical education and innovative pediatric research. As a key sponsor of clinical trials, it contributes to the development and evaluation of novel therapies aimed at improving outcomes for children both nationally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Trial Officials
yukan huang, professor
Study Chair
Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials